Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: Oral Escherichia coli expressing IL-35 meliorates experimental colitis in mice

Fig. 6

E. coli/IL-35 administration attenuated UC by regulating IL-10 and IL-6 levels in serum. The serum concentration of IL-10 was notably elevated post E. coli/IL-35 treatment. The level of IL-6 was markedly increased in DSS and DSS + E. coli/0 groups, which got significantly reduced in E. coli/IL-35 group. n = 10 mice per group. Compared with the DSS group, *p < 0.05; compared with the DSS + E. coli/0 group, *p < 0.05

Back to article page